Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
8.49
+0.23 (2.78%)
Jan 7, 2026, 4:00 PM EST - Market closed
Korro Bio Market Cap
Korro Bio has a market cap or net worth of $79.95 million as of January 8, 2026. Its market cap has decreased by -80.80% in one year.
Market Cap
79.95M
Enterprise Value
22.13M
1-Year Change
-80.80%
Ranking
Category
Stock Price
$8.49
Market Cap Chart
Since November 6, 2023, Korro Bio's market cap has decreased from $123.80M to $79.95M, a decrease of -35.42%. That is a compound annual growth rate of -18.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 77.79M | 3.12% |
| Dec 31, 2025 | 75.43M | -78.85% |
| Dec 31, 2024 | 356.65M | -6.96% |
| Dec 29, 2023 | 383.31M | 209.63% |
| Nov 6, 2023 | 123.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |